This report analyses the financial performance of Zur Rose for the 2019. You will find all the necessary details regarding company's profitability, volume growth, indebtedness and a comparison with selected peers.
Zur Rose announced a net loss of CHF 52.4 mil in 2019, down 34.4% when compared to the last year. Sales increased 12.3% yoy to CHF 1,356 mil, EBITDA rose 1.16% to CHF -13.8 mil and net margin amounted to -3.86%. Zur Rose stock appreciated 19.3% in 2019 to CHF 107 per share and the stock traded at 12-month trailing PE of -17.7 and EV/EBITDA of -84.8x at the end of 2019.
The key highlights are:
Sales increased 12.3% yoy to CHF 1,356 mil in 2019. That’s compared to average growth of 15.5% in the last three years and 9.89% when compared to the average annual increase in the last decade.
EBITDA amounted to CHF -13.8 mil and grew 1.16% when compared to last year. EBITDA margin reached -1.02%, down 0.581 pp when compared to 5-year average.
Company’s indebtedness rose when measured by Net Debt/Equity and reached 57.4% at the end of the year. When compared to EBITDA, net debt fell to -16.8x.
Zur Rose netted CHF -52.4 mil to its shareholders in the last year, up 91.2% when compared to the average seen in the last five years. The company produced a return on capital of -9.90% and return on equity of -12.3% in the last year.
Zur Rose stock traded at CHF 107 per share at the end of 2019 implying a market capitalization of USD 961 mil and enterprise value of USD 1,202 mil. This puts the stock at the 12-month trailing price to earnings of -17.7x and EV/EBITDA of -84.8x as of the end of 2019. Over the last five years, the stock price has increased by 35% a year on average and the firm generated its shareholders an average return on equity of -10.2%.
Helgi Library 
